Addressing Vulnerability in Clinical Trials Involving People Living with Dementia in Long-term Care Homes
Conducting clinical trials in long-term care homes may render people living with dementia vulnerable to autonomy wrongs, welfare wrongs, and justice wrongs. In this session, Dr. Charles Weijer will present a systematic approach to identify and mitigate vulnerabilities that arise in these trials. He will share how we can put added protections in place to mitigate each vulnerability while maintaining a trial’s scientific validity.
Dr. Charles Weijer, Professor of Medicine and Philosophy, Western University
Indigenous Representation in Clinical Trials: Towards a future of equity and inclusion in research for Indigenous Peoples
Dr. Brittany Bingham, Director, Indigenous Research Indigenous Health | Vancouver Coastal Health Centre for Gender & Sexual Health Equity (CGSHE) Assistant Professor, Social Medicine | UBC
Post Pandemic Call to Action: Inclusivity
Historical data indicates that clinical study population may not represent the real world population. Regulatory agencies are taking a closer look at representation in clinical studies. As an industry, we can make impactful changes and contributions to ensure inclusive clinical research.
Melaina Boyce, Head of In-Country Clinical Study Operations, USA, Canada, & LATAM, EMD Serono Research and Development Institute
The Importance of Research in Community Hospitals
Community hospitals care for the most patients, yet nearly all patient-based research is done at larger, academic hospitals. In this session Dr. Jennifer Tsang will discuss why it’s important for community hospitals to be involved in health research, and steps to increase engagement.
Dr. Jennifer LY Tsang, Physician Research Lead, Intensivist, Niagara Health, Physician Co-Lead, Critical Care Research Program, Niagara Health; Regional Deputy Research Director, Internal Medicine Residency Program, McMaster University; Associate Professor of Medicine, McMaster University
Transparency, Responsible Research Practices, and Clinical Trial Reporting
How do we foster transparency, restore public trust in research, and make research results more useful to end-users? Institutions and individual scientists are yet to adopt the new tools that can help to attain this tall order. In this presentation, the “upstream” effects of research reporting standards will be examined.
Dr. Martin Offringa, Paediatrician, Trialist, Senior Scientist, The Hospital for Sick Children Toronto
KEYNOTE: Infodemic! Is Misinformation Killing Us?
The spread of misinformation seems to intensify with each passing week. Indeed, it is a defining characteristic of our time! And research tells us that misinformation is doing tangible harm — to public health, mental health, public discourse, personal relationships, and public trust. How did we get here, why do people believe, and what can we do about it? In this presentation Professor Timothy Caulfield explores what the most recent evidence tells us about the nature and source of the current infodemic. He will also provide science-informed recommendations about how best to engage individuals and communities.
Timothy Caulfield, Professor of Health Law and Science Policy | Bestselling Author